WASHINGTON A congressional vote on a Republican healthcare plan may not come for weeks as leaders in the House of Representatives and the Senate continue negotiations over possible proposals, the White House said on Monday.
- NASH: The next untapped pharma market gives investors many options |
- Mindfulness-based stress reduction only slightly improves low back pain
- Poorest preschoolers most vulnerable to fatal child abuse
- Sanofi files U.S. antitrust lawsuit against Mylan over EpiPen
- Canada recommends against testing everyone for hepatitis C
(Reuters Health) - Consuming too much choline, a nutrient sold in over-the-counter dietary supplements, can boost the risk for blood clots, researchers warn.
(Reuters Health) - Death of a sibling in childhood is associated with a greater risk of early death in the surviving brother or sister, researchers say.
Eli Lilly and Co said the combination of its experimental breast cancer drug and a commonly used treatment met the main goal of a late-stage study in an interim analysis, setting the stage for a regulatory submission later this year.
Pharmacy benefit manager Express Scripts Holding Co said Anthem Inc, its biggest customer and one that has sued the company over claims of being overcharged, was unlikely to renew its contract after it ends in 2019.
Saba Imtiaz’s novel, “Karachi, You’re Killing Me!” is a breezy if superficial read - a Pakistani “Bridget Jones’s Diary” of sort that captures the misadventures of a blundering young journalist and her struggle to land the big story and the right man. “Noor”, the official movie adaptation, certainly imbibes the bumbling character of the protagonist, but the breeziness and humour are sorely missing.